4.6 Article

Overall survival time prediction for glioblastoma using multimodal deep KNN

Journal

PHYSICS IN MEDICINE AND BIOLOGY
Volume 67, Issue 13, Pages -

Publisher

IOP Publishing Ltd
DOI: 10.1088/1361-6560/ac6e25

Keywords

glioblastoma; overall survival time; deep KNN; inter-modality loss

Funding

  1. National Natural Science Foundation of China [62073012]
  2. Beijing Municipal Natural Science Foundation [7222307]

Ask authors/readers for more resources

In this study, a novel deep KNN-based OS time prediction method is proposed, which is more robust to data inconsistency and noise compared to end-to-end prediction methods. Moreover, a new inter-modality loss is introduced to extract complementary features from multiple imaging modalities. Experimental results on both an in-house dataset and a public dataset demonstrate that our method outperforms existing methods.
Glioblastoma (GBM) is a severe malignant brain tumor with bad prognosis, and overall survival (OS) time prediction is of great clinical value for customized treatment. Recently, many deep learning (DL) based methods have been proposed, and most of them build deep networks to directly map pre-operative images of patients to the OS time. However, such end-to-end prediction is sensitive to data inconsistency and noise. In this paper, inspired by the fact that clinicians usually evaluate patient prognosis according to previously encountered similar cases, we propose a novel multimodal deep KNN based OS time prediction method. Specifically, instead of the end-to-end prediction, for each input patient, our method first search its K nearest patients with known OS time in a learned metric space, and the final OS time of the input patient is jointly determined by the K nearest patients, which is robust to data inconsistency and noise. Moreover, to take advantage of multiple imaging modalities, a new inter-modality loss is introduced to encourage learning complementary features from different modalities. The in-house single-center dataset containing multimodal MR brain images of 78 GBM patients is used to evaluate our method. In addition, to demonstrate that our method is not limited to GBM, a public multi-center dataset (BRATS2019) containing 211 patients with low and high grade gliomas is also used in our experiment. As benefiting from the deep KNN and the inter-modality loss, our method outperforms all methods under evaluation in both datasets. To the best of our knowledge, this is the first work, which predicts the OS time of GBM patients in the strategy of KNN under the DL framework.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available